The EU Cyber Resilience Act and Your Legacy Software: A Survival Guide for Life Science OEMs

If you build laboratory or analytical equipment that ships into Europe, the clock is already running. The EU Cyber Resilience Act (CRA) entered into force on 10 December 2024, and the first hard deadlines arrive in just a few months. For life science OEMs whose instruments rely on software written years (or decades) ago, that is not a comfortable position to be in.

This article explains, in plain terms, what the CRA actually requires, why legacy life science software is particularly exposed, and how to get compliant without rebuilding your entire product line from scratch.

Already know you have a problem? Book a free CRA Readiness Audit with TotalLab →

What is the Cyber Resilience Act, and why should life science OEMs care?

The CRA is the EU’s first horizontal cybersecurity regulation for “products with digital elements” (PDEs). In practice, that means almost any hardware product sold in the EU that contains software or connects to a network, plus any standalone software product, falls inside its scope.

For life science OEMs, this is broader than most people realize. Gel imaging systems, plate readers, sequencers, mass spectrometers, microarray scanners, colony counters, electrophoresis equipment, anything with embedded firmware, a PC interface, or an analysis package shipped alongside it, sits squarely inside the CRA’s remit.

Three dates matter:

11 June 2026. Member states begin notifying conformity assessment bodies under the CRA framework.
11 September 2026. Mandatory vulnerability and incident reporting begins. Manufacturers must notify actively exploited vulnerabilities within 24 hours and submit a full report within 72 hours.
11 December 2027. Full application. From this date, no non-compliant product with digital elements can be placed on the EU market.

The penalties are not symbolic. Non-compliance with the essential cybersecurity requirements can attract administrative fines of up to €15 million or 2.5% of global annual turnover, whichever is higher.

Why legacy life science software is uniquely exposed

A lot of the analysis software running on life science instruments today was written long before “secure by design” was even a phrase. Some of it dates back fifteen or twenty years. It often:

Runs on outdated frameworks or unsupported operating systems
Has no Software Bill of Materials (SBOM), so nobody knows exactly which open-source components are baked in
Lacks a documented vulnerability handling process
Was never built with secure update mechanisms, signed binaries, or modern authentication
Has no formal documentation of cybersecurity risk assessment

That worked fine when the regulatory bar was 21 CFR Part 11 and EU Annex 11 (which TotalLab has been helping OEMs meet for over two decades). It will not work for the CRA. The CRA’s Annex I requires manufacturers to identify and document vulnerabilities and components, including drawing up an SBOM in a commonly used and machine-readable format. If you cannot produce that document for an instrument you shipped in 2018, you have a problem.

And here is the part most OEMs miss: the reporting obligations from September 2026 apply to products already on the EU market, not just new ones. If a critical vulnerability in a third-party library used inside your instrument’s software is added to a known-exploited list, you are required to detect it and report it within 24 hours. You cannot report what you cannot see, and most legacy software estates simply have no visibility into their own dependencies.

What “compliant” actually looks like under the CRA

To place a product with digital elements on the EU market from December 2027, manufacturers will need to demonstrate, among other things:

Secure-by-design development. Cybersecurity considered from the planning stage, not bolted on at the end.
A complete, machine-readable SBOM. Covering at least top-level dependencies.
A documented vulnerability handling process. Including coordinated disclosure, security updates, and a way to deliver them throughout the support period (defaulted to five years).
Conformity assessment. Self-assessment for most products, third-party assessment for “important” and “critical” categories.
CE marking and EU Declaration of Conformity based on cybersecurity, not just safety.
Technical documentation demonstrating how each essential requirement has been met.
Operational reporting capability for the September 2026 deadline.

For a life science OEM with a portfolio of instruments running heritage software, that is a lot of work. The temptation is to either ignore it (risky) or to assume an in-house dev team can absorb it alongside their existing roadmap (almost always unrealistic given the timelines).

The third option: redevelop the software, keep the hardware

Most life science instruments are mechanically excellent and commercially valuable. The problem is rarely the box; it is the software wrapped around it. The CRA does not require you to scrap your hardware. It requires the digital elements that ship with that hardware to meet modern cybersecurity standards.

That opens up a much more pragmatic path: redevelop or modernize the software layer, leaving your hardware engineering, your supply chain, and your sales channels intact.

This is exactly the work TotalLab has been quietly doing for global life science OEMs for years. Our dedicated CRA compliance service for OEMs is built around exactly this pattern: keep your hardware, modernize your software, stay in Europe.

Why TotalLab is built for this problem

We are not a generic software house that has decided life sciences looks interesting. TotalLab has spent over two decades building software exclusively for the life science industry. Our team includes PhD-educated life scientists alongside software engineers and AI specialists, which means when an OEM partner says “this instrument runs a 2D-PAGE workflow with DIGE statistics and needs to integrate with a LIMS,” we know precisely what they mean.

We already partner with several of the world’s largest life science equipment manufacturers, building and maintaining the analysis software that ships with their instruments. We have done this under 21 CFR Part 11, under EU Annex 11, and under GMP. We are now actively helping OEM partners extend that compliance work to cover the CRA’s essential cybersecurity requirements.

A few things make this work move faster with us than with a generalist:

We have done this before. Migrating legacy life science codebases onto modern, supportable, secure architectures is core business for our custom development team. We know where the landmines are.
AuditSafe gives you a head start. Our AuditSafe platform already provides 21 CFR Part 11 / EU Annex 11 / GMP-compliant audit trails, user management, electronic signatures and data integrity controls that map directly onto several of the CRA’s essential requirements. It can be wrapped around existing software or hardware, dramatically shortening time to market.
We understand the science. Your sales team will not be explaining what a Western blot is, or why band quantification matters. We already know.
We work white-label. Everything we build for OEM partners can ship under your brand. Your customers see your product, not ours.
We de-risk the regulatory side. We have helped clients navigate FDA approvals for therapeutic drugs and devices. CRA documentation, conformity assessment evidence, and SBOM generation are extensions of work we already do.

A typical CRA modernization engagement

Every project is different, but the rough shape of a CRA-driven modernization program looks like this:

Audit and scoping. We assess your current software estate, identify which products fall inside the CRA’s scope, classify them against the CRA’s product categories, and produce a gap analysis against the essential requirements. We offer this initial readiness audit free of charge as the first step of any CRA engagement.
SBOM generation. We produce machine-readable software bills of materials for the in-scope products so you can meet the September 2026 reporting obligation.
Architecture decisions. Where legacy code can be remediated, we remediate. Where it genuinely cannot, we redevelop on a modern, supportable stack while preserving the user-facing workflows your customers know.
Secure development and validation. We rebuild or refactor under secure-by-design principles, with documented vulnerability handling, signed updates, and full technical documentation.
Compliance evidence. We produce the documentation pack you need for conformity assessment and CE marking.
Ongoing maintenance. The CRA expects security support throughout the product’s expected lifetime. We can take that on as a managed service, or hand it back to your internal team with full documentation.

You almost certainly have less time than you think

Twelve months feels like a lot. It isn’t. Between scoping, design, development, testing, validation, documentation, conformity assessment, and getting your sales and support teams trained on the new product, a serious CRA modernization program for an instrument with non-trivial legacy software typically runs nine to eighteen months.

The OEMs that are starting conversations now will comfortably hit the December 2027 deadline. The ones still telling themselves they will “look at it next year” are the ones who will quietly stop being able to ship into Europe.

If you are an OEM with legacy software that needs to be CRA-ready, and you would rather modernize than rebuild from scratch, the conversation is the same conversation we are already having with several of the largest names in the industry. We would be very happy to add you to that list.

Find out exactly where you stand

The fastest way to know whether your portfolio is exposed is to take us up on a free CRA Readiness Audit. One discovery call, a structured review of your in-scope products, and you walk away with a clear gap analysis, a prioritized roadmap to December 2027, and an honest view of whether remediation or redevelopment is the right call for each product. No commitment, no sales handoff, just clarity.

Book your free CRA Readiness Audit →

Or learn more about:

Frequently asked questions

Does the Cyber Resilience Act apply to life science laboratory equipment?

Yes, in almost all cases. The CRA applies to any “product with digital elements” placed on the EU market. Lab and analytical instruments that contain firmware, ship with analysis software, or connect to a network or computer fall inside its scope. Medical devices regulated under the MDR or IVDR have their own cybersecurity provisions, but research-use-only and non-medical laboratory equipment is firmly within the CRA.

What happens if our legacy software is not CRA compliant by December 2027?

From 11 December 2027, products with digital elements that do not meet the CRA’s essential requirements cannot be placed on the EU market. Existing units already in customers’ labs are not retroactively pulled, but you cannot ship new ones, and reporting obligations for actively exploited vulnerabilities apply to your fielded fleet from 11 September 2026 regardless. Penalties for non-compliance can reach €15 million or 2.5% of global annual turnover.

Can we just patch our legacy software, or do we need to redevelop?

It depends on the codebase. Some legacy products can be remediated with significant refactoring, secure update infrastructure, and a robust SBOM. Others, particularly those built on unsupported frameworks or end-of-life operating systems, are more economically rebuilt. TotalLab’s free CRA readiness audit is designed to give you a clear, evidence-based answer for each product in your portfolio.

How long does a CRA modernization program usually take?

For a single instrument with moderate software complexity, typical engagements run nine to eighteen months from kickoff to a fully compliant, documented, conformity-assessed product. Multi-product portfolios can be sequenced in parallel. The earlier you start, the more options you have.

Does TotalLab work white-label?

Yes. Almost all our OEM software ships under our partners’ brands. Your customers see your product, your branding, your support journey. We work behind the scenes.